Back to Search
Start Over
How to monitor safety and efficacy of biologic treatment in rare, therapy-refractory immune-mediated inflammatory diseases?: Making the right clinical decisions for rare diseases with the right tools
- Source :
- Rheumatology (Oxford, England), 57(4), 591-593. Oxford University Press
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 14620324
- Database :
- OpenAIRE
- Journal :
- Rheumatology (Oxford, England), 57(4), 591-593. Oxford University Press
- Accession number :
- edsair.narcis........ddaada87596a8875736142d5ab80b220